Chemotherapy of advanced epithelial cancer–a critical review (1992)

Peer-Reviewed Study · Ulrich Abel · 1992

Ulrich Abel, 1992: Abel's English-language summary of his 1990 report: a review of trials plus replies from hundreds of oncologists, concluding that outside small-cell lung cancer there is no direct evidence chemotherapy prolongs survival in advanced carcinoma. He names ovarian cancer as the one site where indirect evidence points the other way, and says benefit there and in lung cancer is at best small.

Apart from lung cancer, in particular small-cell lung cancer, there is no direct evidence that chemotherapy prolongs survival in patients with advanced carcinoma. Except for ovarian cancer, available indirect evidence rather supports the absence of a positive effect.

Abstract (journal p. 439)

Ulrich Abel, 1992: Abel's English-language summary of his 1990 report: a review of trials plus replies from hundreds of oncologists, concluding that outside small-cell lung cancer there is no direct evidence chemotherapy prolongs survival in advanced carcinoma. He names ovarian cancer as the one site where indirect evidence points the other way, and says benefit there and in lung cancer is at best small. Funder: none declared. COI: no disclosure statement in the 1992 record. Comparator: analysis of published trials and oncologist survey responses, not a new trial; comparisons are chemo vs no chemo / less aggressive chemo. Full text is paywalled; abstract read on PubMed and quoted verbatim. Abel also states elsewhere in the abstract that some sub-groups may benefit but cannot be defined from available results, and that benefit in quality of life is unclear. Study type: review.